联合介入治疗主动脉夹层并冠心病的安全性及临床疗效
Joint intervention in the treatment of thoracic aortic dissection and coronary heart disease safety and clinical efficacy
摘要目的 评价覆膜支架联合PCI介入治疗Stanford B型主动脉夹层并冠心病的安全性及临床疗效.方法 2002年1月至2008年6月完成的20例先后行覆膜支架联合PCI治疗Stanford B型主动脉夹层并冠心病患者,观察住院及随防期间覆膜支架内漏、冠状动脉支架血栓形成、心力衰竭、死亡、截瘫、肾功能情况.结果 手术成功率100%,术后即刻造影16例近端破口完全封堵,4例少量残余内漏,无截瘫、肾功能不全、心力衰竭、心绞痛、亚急性血栓形成、死亡,随防6个月至2年,复查腹主动脉增强CT示夹层支架封闭良好.结论 覆膜支架联合PCI介入治疗Stanford B型主动脉夹层并冠心病安全、有效.
更多相关知识
abstractsObjective To evaluate the clinical efficacy and safety of interventional treatment in patients with Stanford B thoracic aortic dissection and coronary heart disease by endovascular graf exclusion (EVGE) and percutaneous coronary intervention(PCI) respectively.Methods From January 2002 to June 2008,20 patients with Stanford B thoracic aortic dissection and coronary heart disease received successive EVGE and PCI in our hospital,Observed during hospitalization and follow-EVGE endoleak,Coronary stent thrombosis,heart failure,death,paraplegia,renal function.Results 100 percent success rate of surge-ry,immediately after the 16 cases of proximal contrast break completely sealing,four cases with a small amount of residual leakage,no paraplegia,renal insufficiency,heart failure,angina,subacute thrombosis,death,with the anti-6 months to 2 years,a review of abdominal aortic dissection stent enhanced CT showed good closure.Conclusion Joint intervention in the treatment of thoracic aortic dissection and coronary heart disease is safe and effective.
More相关知识
- 浏览128
- 被引2
- 下载36

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



